(Q32049276)

5 July 2017

1 reference

title

Narcolepsy: new understanding of irresistible sleep (English)

1 reference

5 July 2017

0 references

L E Krahn

1

1 reference

5 July 2017

J L Black

series ordinal

2

1 reference

5 July 2017

M H Silber

series ordinal

3

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

5 July 2017

1 reference

5 July 2017

volume

76

1 reference

5 July 2017

issue

2

1 reference

5 July 2017

page(s)

185-194

1 reference

Hypocretin (orexin) deficiency in human narcolepsy.

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

7 January 2021

Sleep and narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Studies in psychophysiology of dreams. III. The dream of narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

NOCTURNAL SLEEP OF NARCOLEPTICS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Sleepiness in different situations measured by the Epworth Sleepiness Scale.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

The role of actigraphy in the evaluation of sleep disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

A normative study of the maintenance of wakefulness test (MWT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

The pupillogram and narcolepsy. A method to measure decreased levels of wakefulness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Diagnosing narcolepsy through the simultaneous clinical and electrophysiologic analysis of cataplexy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

A standardized test for cataplexy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

The clinical spectrum of narcolepsy and idiopathic hypersomnia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Genetic and familial aspects of narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Pontine lesions in idiopathic narcolepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

MRI findings in narcolepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Dopamine‐receptor autoradiography of human narcoleptic brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

CSF substance P somatostatin and monoaminergic transmitter metabolites in patients with narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Circadian temperature and activity rhythms in unmedicated narcoleptic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Neurons containing hypocretin (orexin) project to multiple neuronal systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Genetic studies in the sleep disorder narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Distribution of orexin neurons in the adult rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Distribution of orexin receptor mRNA in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Reduced number of hypocretin neurons in human narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Evaluation of treatment with stimulants in narcolepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Natural history, symptoms and treatment of the narcoleptic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Compliance with stimulant medications in patients with narcolepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Sleep practitioners need to be aware of new changes in the labeling of pemoline (CYLERT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Use of modafinil in the treatment of narcolepsy: a long term follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Relative Efficacy of Drugs for the Treatment of Sleepiness in Narcolepsy

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

inferred from DOI database lookup

7 January 2021

based on heuristic

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Non-pharmacological approaches to the treatment of narcolepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

The alerting effects of short and long naps in narcoleptic, sleep deprived, and alert individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Fluoxetine in the treatment of cataplexy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Serotoninergic reuptake mechanisms in the control of cataplexy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Pharmacological aspects of human and canine narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Short-Term Triazolam Use Improves Nocturnal Sleep of Narcoleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

Introduction to the mechanism of action of different treatments of narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Scheduled naps in the management of daytime sleepiness in narcolepsy-cataplexy.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963126-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(11)63126-1

0 references

1 reference